Sequel Pharmaceuticals Inc — Form D
Sequel Pharmaceuticals Inc of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-12-23. The offering totals $9.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-12-23
- Form: D
- Accession: 0001346301-10-000008
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $9.0M
- Amount sold: $1.0M
- Remaining: $8.0M
- Investors: 10
- Date of first sale: 2010-12-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-152498
Issuer
- Name: Sequel Pharmaceuticals Inc
- CIK: 0001414879
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 12790 EL CAMINO REAL, San Diego, CA, 92130
- Phone: (858) 509-0455
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Stuart JM Collinson | Director | Austin, TX |
| Joseph K Turner | Director | San Diego, CA |
| Daniel K Turner, III | Director | San Diego, CA |
| Eckard K Weber | Director | San Diego, CA |
| Randall Woods | Director | Sunnyvale, CA |
| Paul K Chamberlain | Executive Officer | San Diego, CA |
| Howard C Dittrich | Executive Officer | Sunnyvale, CA |
| Brian K Farmer | Executive Officer | San Diego, CA |
| Mark C Murgerditchian | Executive Officer | San Diego, CA |
| Randall Woods | Executive Officer | Sunnyvale, CA |
| David Lowe | Director | Walnut Creek, CA |
| Joseph Turner | Director | Boston, MA |
| Nina Kjellson | Director | Santa Clara, CA |
| Eckard Weber | Director | SAN DIEGO, CA |
| Nina K Kjellson | Director | San Diego, CA |
| David K Lowe | Director | San Diego, CA |
| Mark Murgerditchian | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More